Swan Global Investments LLC Buys 579 Shares of UnitedHealth Group Incorporated $UNH

Swan Global Investments LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 101.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,147 shares of the healthcare conglomerate’s stock after purchasing an additional 579 shares during the quarter. Swan Global Investments LLC’s holdings in UnitedHealth Group were worth $358,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cidel Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 20.7% during the second quarter. Cidel Asset Management Inc. now owns 6,511 shares of the healthcare conglomerate’s stock worth $2,031,000 after buying an additional 1,118 shares in the last quarter. Crux Wealth Advisors increased its holdings in UnitedHealth Group by 10.6% in the 2nd quarter. Crux Wealth Advisors now owns 2,002 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 192 shares in the last quarter. Chicago Partners Investment Group LLC boosted its stake in shares of UnitedHealth Group by 26.4% during the second quarter. Chicago Partners Investment Group LLC now owns 4,606 shares of the healthcare conglomerate’s stock valued at $1,347,000 after purchasing an additional 962 shares in the last quarter. Sigma Investment Counselors Inc. increased its stake in shares of UnitedHealth Group by 5.8% in the second quarter. Sigma Investment Counselors Inc. now owns 14,130 shares of the healthcare conglomerate’s stock valued at $4,408,000 after buying an additional 769 shares during the period. Finally, Sims Investment Management LLC raised its holdings in UnitedHealth Group by 3.9% in the 2nd quarter. Sims Investment Management LLC now owns 1,087 shares of the healthcare conglomerate’s stock valued at $339,000 after buying an additional 41 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.0%

Shares of UNH stock opened at $356.53 on Monday. The company has a market cap of $322.90 billion, a P/E ratio of 15.45, a PEG ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a 50 day simple moving average of $329.38 and a two-hundred day simple moving average of $342.24. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the firm posted $6.80 earnings per share. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analysts Set New Price Targets

Several brokerages have issued reports on UNH. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Jefferies Financial Group increased their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday. Mizuho upped their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.